Literature DB >> 21203354

Human growth factor cream and hyaluronic Acid serum in conjunction with micro laser peel: an efficient regimen for skin rejuvenation.

Michael H Gold, Bruce E Katz, Joel L Cohen, Julie Biron.   

Abstract

The present study investigated the use of a novel hyaluronic acid serum in combination with a cream comprising a mixture of human growth factors in conjunction with the micro laser peel procedure for skin rejuvenation. After preconditioning the face with the hyaluronic acid serum followed by the cream twice daily for one month, 15 female volunteers between 35 to 65 years of age with demonstrable facial wrinkling received a micro laser peel on the entire face using an erbium-doped yttrium aluminium garnet laser. Immediately following the laser procedure, the subjects applied the test products twice daily until the second laser peel one month later. Immediately following the second procedure, the subjects reapplied the test products for another month. In the large majority of subjects, erythema or edema, crusts or erosions, and transitory stinging or burning sensations after the micro laser peel were minimal or mild when the skin was treated with the serum followed by the cream. The micro laser peel in conjunction with the test products helped to significantly improve hyperpigmentation, wrinkles, and texture as compared to before treatment. This study with the micro laser peel device demonstrated that a novel hyaluronic acid serum combined with the human growth factor cream can be successfully used for skin rejuvenation in conjunction with light-to-medium invasive laser skin treatments.

Entities:  

Year:  2010        PMID: 21203354      PMCID: PMC3013551     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  15 in total

1.  Combined 633-nm and 830-nm led treatment of photoaging skin.

Authors:  David J Goldberg; Snehal Amin; Bruce A Russell; Robert Phelps; Norma Kellett; Laurence A Reilly
Journal:  J Drugs Dermatol       Date:  2006-09       Impact factor: 2.114

2.  Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation.

Authors:  Michael H Gold; Mitchel P Goldman; Julie Biron
Journal:  J Drugs Dermatol       Date:  2007-02       Impact factor: 2.114

Review 3.  Photodynamic therapy with lasers and intense pulsed light.

Authors:  Michael H Gold
Journal:  Facial Plast Surg Clin North Am       Date:  2007-05       Impact factor: 1.918

4.  A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy.

Authors:  Michael H Gold; Julie Biron
Journal:  J Drugs Dermatol       Date:  2006-09       Impact factor: 2.114

Review 5.  Hyaluronan.

Authors:  T C Laurent; J R Fraser
Journal:  FASEB J       Date:  1992-04       Impact factor: 5.191

Review 6.  Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin.

Authors:  M B Brown; S A Jones
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-05       Impact factor: 6.166

7.  Transforming growth factor beta 1-hyaluronic acid interaction.

Authors:  P Locci; L Marinucci; C Lilli; D Martinese; E Becchetti
Journal:  Cell Tissue Res       Date:  1995-08       Impact factor: 5.249

8.  Clinical, histologic, and ultrastructural changes after use of human growth factor and cytokine skin cream for the treatment of skin rejuvenation.

Authors:  Mussarrat Hussain; Robert Phelps; David J Goldberg
Journal:  J Cosmet Laser Ther       Date:  2008-06       Impact factor: 2.247

Review 9.  Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects.

Authors:  G Weindl; M Schaller; M Schäfer-Korting; H C Korting
Journal:  Skin Pharmacol Physiol       Date:  2004 Sep-Oct       Impact factor: 3.479

10.  Human growth factor and cytokine skin cream for facial skin rejuvenation as assessed by 3D in vivo optical skin imaging.

Authors:  Michael H Gold; Mitchel P Goldman; Julie Biron
Journal:  J Drugs Dermatol       Date:  2007-10       Impact factor: 2.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.